Getting real value out of IoT (Internet of Things) can be viewed as a ‘perfect storm’ in the sense that it presents a rare combination of circumstances with the potential to result in an event of unusual magnitude. IoT can be defined as physical objects that are connected to a network to collect data, like a fitness tracker recording personal activity data.
Internet of things in the lab In the context of the laboratory, the direct interfacing of objects removes the need for manual data entry or transcription, which safeguards the integrity of the collected data, as well as aiding compliance with standards and regulations like 21 CFR Part 11. Efficiency is boosted through the removal of non-value-adding activity, while more data (and more complete data) of higher quality is collected, being attributable (who created a record and when), legible, contemporaneous, original and accurate.
In addition to providing a greater volume of complete data, the IoT gives an overview of processes and activity. Once analytics are applied, insight can be gained into trends or the effect of implemented changes, enabling organizations to act in a pre-emptive manner. When an organization has disconnected standalone equipment, however, it becomes difficult to obtain such an overview, especially when devices may be spread in various locations around the world. Questions can then arise as to whether each device is correctly calibrated, its maintenance status, where this information is documented, and how the data can be linked to that of the samples being tested in order to provide evidence that the instrument was in perfect working order during the time of measurement.
From a cost perspective, having detailed information regarding the location of equipment and how it is being used may reveal that instruments could be relocated,or used in a more efficient way rather than an organization needing to incur the cost of purchasing additional equipment. However, there are two key difficulties in leveraging this data; the first being that the documentation often remains in the form of paper records or Excel spreadsheets; and the second is the equipment being disconnected, making the access to data difficult.
This story is from the Pharma Bio World December 2018 edition of Pharma Bio World.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the Pharma Bio World December 2018 edition of Pharma Bio World.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
B&R Expands Gilgenberg Site
Automation specialist invests in production, office space and logisticsB&R is investing in its Gilgenberg site, located a few kilometers from the B&R headquarters in Eggelsberg. The expansion adds new offices, training rooms and production space. A new logistics hall has also been opened at the site.
Creating An Annual Event Of The Biopharma Industry By Focusing On Frontiers, & Promoting Leading Enterprises To Collaborate
The Union Budget 2018 was presented on February 1, 2018.
Pain Point To Gaining Brownie Points: Technology Is A Game Changer For Indian Pharma Sector
The Indian pharmaceutical industry has come a long way from traditional home-made herbal medicines to being the manufacturer of world class life-saving drugs. However, at the helm of game-changing innovations steering this industry to a whole new level is the implementation of technology.
Data Acquisition, Evaluation And Transmission To The Cloud
A single device to acquire data, evaluate it and send it to the cloud – that’s now possible with B&R’s Edge Controller. The powerful industrial PC can even be used for big data analysis and machine learning, while at the same time serving as a full-fledged industrial controller.
Just The Right Dose Of Intelligence
Nothing herein shall constitute an offer to sell, or a solicitation of an offer to buy. The ACOPO Strak product is not available for sale into the United States of America until September 2018.
Considerations For Extraction, Stabilization And Quantification By PCR For Sensitive Sample Such As RNA
This article talks about careful selection of an extraction system that helps stabilize and protect targets, especially RNA, or which allows for immediate analysis.
Novel Research In Pharmaceuticals And Bio-Pharmaceuticals
This article covers entire spectra of pharmaceutical research and as well as those related to synthesis and processing of pharmaceuticals.
Boost Productivity With Anti-sloshing
Transport liquids faster without spills With B&R’s industrial transport system, it is now possible to transport liquids quickly with no spills. SuperTrak is the only system on the market to offer anti-sloshing technology. This technology suppresses the format ion of oscillations on free surfaces to prevent liquids from spilling over container edges during transport .
Rational Use Of Drugs And Irrational Drug Combinations
Irrational use of medicines is a global phenomenon. Rational use of drugs may be defined as: Patients receive medications appropriate to their clinical needs, in doses that meet their own individual requirements, for an adequate period of time, and the lowest cost to them and their community. Overuse, polypharmacy and incorrect use of drugs are the most common problems of drug use today. Irrational use of drugs may result due to various reasons at various levels including the prescribing errors and over the counter drugs. Irrational use of medicines may lead to serious negative health and economic consequences. Many irrational drug combinations are available in the Indian market. Proper implementation of rational use of drugs will improve the quality of life and result in better community healthcare.
Cold Chain Management For Sensitive Goods
Packaging, route planning and risk analysis ensure safe conditions during transportation of delicate drugs. Drugs are sensitive goods to transport, which can be subject to irreversible damage if they are stored or transported at temperatures outside the tolerated range. If the temperature falls below or rises above the specified range the quality of drugs requiring refrigeration can be seriously affected and they may cease to be effective. This article therefore describes how transport conditions during the transportation of drugs can be optimised through suitable packaging, individualised process design, the analysis and assessment of potential risks and close collaboration between the sender and the freight carrier.